MedPath

The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.

Phase 1
Completed
Conditions
HIV Infections
Registration Number
NCT00145561
Lead Sponsor
Radboud University Medical Center
Brief Summary

Pharmacokinetic study of Saquinavir and Ritonavir in HIV-infected pregnant women

Detailed Description

It is generally accepted that HIV-infected pregnant women should receive treatment to prevent the transmission of HIV from mother-to-child.The (relative) contra-indications for the NNRTIs during pregnancy make a PI based regimen the most rational choice. Based on several experiences and investigations it is expected that saquinavir will play a role as a component of tripe drug regimens for HIV-infected pregnant women. Since the bid dose regimen of 1,000mg saquinavir and 100mg ritonavir is approved by the regulatory authorities and with the availability of a new 500mg tablet formulation of saquinavir,there is a need for a well-designed pharmacokinetic trial using the new 500mg saquinavir tablet formulation in the above mentioned dose.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • HIV infected woman
  • 18 - 40 years of age
  • able and willing to sign Informed Consent
  • pregnant for a maximum of 31 weeks
Exclusion Criteria
  • history of sensitivity/idiosyncrasy to the drug
  • relevant history of interference with drug metabolism
  • inability to understand trial procedures
  • abnormal specific serum levels
  • use of specific concomitant medications
  • active hepatobiliary or hepatic disease
  • previous failure of saquinavir/ritonavir regimen

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
pharmacokinetics at week 20 and 33 of gestation and 6 weeks post partum
Secondary Outcome Measures
NameTimeMethod
antiviral activity
safety

Trial Locations

Locations (10)

Radboud University Medical Centre Nijmegen

πŸ‡³πŸ‡±

Nijmegen, Netherlands

Erasmus Medical Centre

πŸ‡³πŸ‡±

Rotterdam, Netherlands

Rijnstate Hospital

πŸ‡³πŸ‡±

Arnhem, Netherlands

University of Leiden

πŸ‡³πŸ‡±

Leiden, Netherlands

University of Bonn

πŸ‡©πŸ‡ͺ

Bonn, Germany

University of Cologne

πŸ‡©πŸ‡ͺ

KΓΆln, Germany

Clinic Rajdumri Road Pathumwan

πŸ‡ΉπŸ‡­

Bangkok, Thailand

University Hospital ''Germans Trias i Pujol''

πŸ‡ͺπŸ‡Έ

Barcelona, Spain

Birmingham Heartlands & Sollihull Hospital

πŸ‡¬πŸ‡§

Birmingham, United Kingdom

Chelsea and Westminster Hospital

πŸ‡¬πŸ‡§

London, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath